BRAF and melanoma: Acetylation of B-RAF at lysine 601 by the p300 acetyltransferase promotes B-RAF kinase activity, thereby enhancing the proliferation of melanoma and resistance to B-RAFV600E inhibitors (Dai et al, 2022).